Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL‐stimulated NFATc1 activity

Osteolytic skeletal disorders are caused by an imbalance in the osteoclast and osteoblast function. Suppressing the differentiation and resorptive function of osteoclast is a key strategy for treating osteolytic diseases. Dracorhodin perchlorate (D.P), an active component from dragon blood resin, ha...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cell Mol Med
Main Authors: Liu, Yuhao, Wang, Ziyi, Ma, Chao, Wei, Zhenquan, Chen, Kai, Wang, Chao, Zhou, Chi, Chen, Leilei, Zhang, Qingwen, Chen, Zhenqiu, He, Wei, Xu, Jiake
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7131942/
https://ncbi.nlm.nih.gov/pubmed/31965715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares